Senate Committee Approves Amended FDASLA, Punts Sanders’ Drug Import Amendment

Updated Story The Senate health committee voted Tuesday to advance its version of FDA user fee reauthorization legislation after adding a host of new measures related to the agency’s role and responsibilities, but rejecting Vermont Independent Bernie Sanders’ drug importation and other drug-pricing amendments. Lawmakers added multiple amendments to the committee’s draft Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act at an executive session markup June 14, with several aiming to address the current shortage...